MODERNA
Live / Registered — Registered (as of 16 Jan 2024)
What this means for you
Registered since 16 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88903508
- Registration number
- 7279624
- Mark type
- Stylized text
- Filed
- 06 May 2020
- Published for opposition
- 08 Sept 2020
- Registered
- 16 Jan 2024
- Attorney of record
- John Francis Ward
Goods and services
- Class 001 — Chemicals: biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders and infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use
- Class 005 — Pharmaceuticals: medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and infectious disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents
- Class 042 — Scientific and technological services: scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids
Owner
- ModernaTx, Inc., CAMBRIDGE, MA, US
- ModernaTx, Inc., Cambridge, MA, US
- ModernaTx, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 31 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 31 Mar 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Nov 2023 — USE AMENDMENT FILED
- 01 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 30 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED